Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
lower decrease » linear decrease (Expand Search), larger decrease (Expand Search), we decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
decrease risk » increased risk (Expand Search), increases risk (Expand Search), disease risk (Expand Search)
Showing 41 - 60 results of 23,496 for search '(( significantly ((lower decrease) OR (teer decrease)) ) OR ( significant decrease risk ))', query time: 0.58s Refine Results
  1. 41
    Absolute and relative lower extremity peripheral arterial disease DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile.

    Absolute and relative lower extremity peripheral arterial disease DALYs rate attributable to 2<sup>nd</sup> level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 42
    Mortality risk in patients with CVD and hypertension—Advanced disease.

    Mortality risk in patients with CVD and hypertension—Advanced disease. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  3. 43
    SLE decreases risk for hormonal cancers.

    SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

    Published 2021
    “…(a) Breast cancer incidence in female SLE cohort is significantly decreased by SLE status (OR 0.52, 95% CI 0.35, 0.74, p = 0.0036). …”
    Save to List
    Saved in:
  4. 44
    Risk-adjusted hospitalization costs and length of stay (LOS) associated with left atrial appendage occlusion (LAAO) utilization during valvular heart surgery.

    Risk-adjusted hospitalization costs and length of stay (LOS) associated with left atrial appendage occlusion (LAAO) utilization during valvular heart surgery. by Ayesha P. Ng (15909876)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 45
    Data_Sheet_1_Decrease in wearable-based nocturnal sleep efficiency precedes epileptic seizures.PDF

    Data_Sheet_1_Decrease in wearable-based nocturnal sleep efficiency precedes epileptic seizures.PDF by Laura Gagliano (14378124)

    Published 2023
    “…Furthermore, nocturnal seizures were associated with significantly lower sleep efficiency and higher wake after sleep onset (p < 0.05), as well as increased odds of seizure occurrence following wake (OR: 5.86, 95 % CI: 2.99 to 11.77, p < 0.001).…”
    Save to List
    Saved in:
  6. 46
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 47
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 48
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 49
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 50
    Characteristics of patients with AKI diagnosed using KDIGO definition versus patients diagnosed with AKI by eKDIGO only by the decrease in sCr (deKDIGO).

    Characteristics of patients with AKI diagnosed using KDIGO definition versus patients diagnosed with AKI by eKDIGO only by the decrease in sCr (deKDIGO). by Marina Wainstein (12437091)

    Published 2022
    Save to List
    Saved in:
  11. 51
    Associations between BCG-treated individuals and their controls across different subgroups and overall categories.

    Associations between BCG-treated individuals and their controls across different subgroups and overall categories. by Eugen Wang (17636322)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 52
    Baseline demographic and clinical characteristics of 6,496 cases (patients with NMIBC who received BCG).

    Baseline demographic and clinical characteristics of 6,496 cases (patients with NMIBC who received BCG). by Eugen Wang (17636322)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 53
    Associations between non BCG treated and their controls to be diagnosed with AD or dementia in different subgroups and overall categories.

    Associations between non BCG treated and their controls to be diagnosed with AD or dementia in different subgroups and overall categories. by Eugen Wang (17636322)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 54
    Associations between BCG treated and their controls to be diagnosed with AD or dementia in different subgroups and in all categories.

    Associations between BCG treated and their controls to be diagnosed with AD or dementia in different subgroups and in all categories. by Eugen Wang (17636322)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  15. 55
    Associations between non BCG treated and their controls in different subgroups and overall categories.

    Associations between non BCG treated and their controls in different subgroups and overall categories. by Eugen Wang (17636322)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 56
    APOL1 risk variant expression in HeLa cells leads to lipid accumulation in the absence of decreased cholesterol efflux.

    APOL1 risk variant expression in HeLa cells leads to lipid accumulation in the absence of decreased cholesterol efflux. by Jung-Hwa Ryu (512365)

    Published 2019
    Save to List
    Saved in:
  17. 57
    Risk Illustration.

    Risk Illustration. by Iftikhar Ali Ch (20783753)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 58
    Flowchart of literature screening process.

    Flowchart of literature screening process. by Shangtian Wang (20933822)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 59
    The details of literature inclusion and exclusion.

    The details of literature inclusion and exclusion. by Shangtian Wang (20933822)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 60
    Basic characteristics of included literature.

    Basic characteristics of included literature. by Shangtian Wang (20933822)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: